Engineered Bacteriophages: A Next-Generation Platform for Precision Antimicrobials and Therapeutics
The escalating crisis of antimicrobial resistance (AMR) and the stagnating antibiotic pipeline have renewed interest in bacteriophage therapy. While natural phages offer specificity and low toxicity, their narrow host range, bacterial resistance, and safety concerns limit clinical use. To overcome t...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2026-03-01
|
| סדרה: | Viruses |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1999-4915/18/3/355 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
